Target intelligence / Profile preview

Niemann-Pick C1 messenger RNA (NPC1 mRNA) (NPC1 mRNA)

Target
NPC1 mRNA
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Niemann-Pick C1 (NPC1) messenger RNA is the nucleic acid sequence that encodes the NPC1 protein, a critical mediator of intracellular cholesterol trafficking. Located primarily in the membranes of late endosomes and lysosomes, the resulting NPC1 protein facilitates the egress of unesterified cholesterol into the cytosol for distribution to other organelles (UniProt P11033). Mutations in the NPC1 gene lead to Niemann-Pick disease type C1, a rare and progressive lysosomal storage disorder characterized by severe neurodegeneration and hepatosplenomegaly due to toxic lipid accumulation (NIH MedlinePlus). In drug development, NPC1 mRNA is a primary focus for mRNA replacement therapies, which aim to deliver functional copies of the transcript to restore protein function in patients (Orna Therapeutics). Additionally, the NPC1 protein serves as the essential intracellular receptor for filoviruses, including Ebola and Marburg, making the regulation of its mRNA a potential avenue for antiviral research (PubMed: 21866103). Current therapeutic challenges include the efficient delivery of mRNA across the blood-brain barrier to treat neurological symptoms and managing the potential for innate immune responses to exogenous nucleic acids (PubMed: 32653452).

Other names
NPC1 transcriptNiemann-Pick disease type C1 mRNANPC1 messenger RNA
02

Mechanism of action

mRNA replacement therapy (restoration of functional protein expression)

03

Biological functions

Cholesterol transportLipid homeostasisProtein synthesisViral entry mediation
04

Disease associations

Niemann-Pick disease type C1Ebola virus infectionMarburg virus infectionNeurodegenerative disease
05

Safety considerations

Innate immune activation via TLR7 and TLR8Lipid nanoparticle-associated hepatotoxicityChallenges in crossing the blood-brain barrier for neurological manifestations
06

Interacting drugs

oRNA-NPC1

1 more in the full profile.

07

Biomarkers

7-ketocholesterolCholestane-3β,5α,6β-triolFilipin staining of unesterified cholesterol

Beyond the preview

Go deeper on Niemann-Pick C1 messenger RNA (NPC1 mRNA) (NPC1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niemann-Pick C1 messenger RNA (NPC1 mRNA) (NPC1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call